Skip to main content
SpringerLink
Log in

Effects of Hemoglobin-Based Oxygen Carriers on Blood Coagulation

  • Chapter
  • First Online:
Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

  • 1464 Accesses

Abstract

There have been at least two major concerns with use of HBOCs as resuscitation fluids for traumatic hemorrhage: potential coagulopathy and interference with conventional clinical laboratory coagulation measurements.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abe H, Fujihara M, Azuma H, Ikeda H, Ikebuchi K, Takeoka S, Tsuchida E, Harashima H (2006) Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier with human plasma: effects on coagulation, kallikrein-kinin, and complement systems. Artif Cell Blood Substit Immobil Biotecnol 34(1):1–10

    Article  Google Scholar 

  • Arnaud F, Handrigan M (2006) Coagulation patterns following hemoglobin-based oxygen carrier resuscitation in severe uncontrolled hemorrhagic shock in swine. Transfusion Med 16:290–302

    Article  Google Scholar 

  • Arnaud F, Hammett M, Asher L, Philbin N, Rice J, Dong F, Pearce B, Flournoy WS, Nicholson C, McCarron R, Freilich D (2005) Effects of bovine polymerized hemoglobin on coagulation in controlled hemorrhagic shock in swine. Shock 24(2):145–152

    Article  Google Scholar 

  • Arnaud F, Fasipe D, Philbin N, Rice J, Flournoy WS, Ahlers A, James MF (2007) Hele′t E, Potgieter, Ellis P, McCarron R, Freilich D. Hematology patterns after hemoglobin-based oxygen carrier resuscitation from severe controlled hemorrhage with prolonged delayed definitive care. Transfusion 47:2098–2109

    Article  Google Scholar 

  • Belgrave RL, Hines MT, Keegan RD, Wardrop KJ, Bayly WM, Sellon DC (2002) Effects of a polymerized ultrapurified bovine hemoglobin blood substitute administered to ponies with normovolemic anemia. J Vet Intern Med 16(4):396–403

    Article  Google Scholar 

  • Browdie D, Smith H (1975) Stroma-free hemoglobin. Simplied preparation and in vivo and in vitro effects on coagulation in rabbits. Am J Surg 129(4):365–368

    Article  Google Scholar 

  • Cabrales P, Sun G, Zhou Y, Harris DR, Tsai AG, Intaglietta M, Palmer AF (2009) Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction. J Appl Phys 107:1548–1558

    Google Scholar 

  • Chen J-Y, Scerbo M, Kramer G (2009) A review of blood substitutes: examing the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics (São Paulo) 64:803–813

    Google Scholar 

  • Dade PFA-100 Reagents Package Insert. Newark, DE: Dade Behring Inc; 2005

    Google Scholar 

  • Darlington DN, Delgado AV, Kheirabadi BS, Fedyk CG, Scherer MR, Pusateri AE, Wade CE, Cap AP, Holcomb JB, Dubick MA (2011) Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro. J Trauma-injury Infect Crit Care 71:1152–1163

    Article  Google Scholar 

  • Deusch E, Gamsjager T, Kress HG et al (2003) Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 97:680–683

    Article  Google Scholar 

  • Ekseth K, Abildgaard L, Vegfors M, Berg-Johnsen J, Engdahl O (2002) The in vitro effects of crystalloids and colloids on coagulation. Anaesthesia 57:1102–1108

    Article  Google Scholar 

  • Favaloro EJ (2002) Clinical application of the PFA-100. Curr Opin Haematol 9:407–415

    Article  Google Scholar 

  • Feola M, Simoni J, Canizaro PT, Tran R. Raschbaum G, Behal FJ, Lubbock (1988) Texas. Toxicity of polymerized hemoglobin solutions. Surg Gynecol Obstet 166:211–222

    Google Scholar 

  • Harrison P, Robinson M, Liesner R et al (2002) The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol 4:225–232

    Article  Google Scholar 

  • Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB et al (2010) Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 69(3):489–500

    Article  Google Scholar 

  • Huang Y, Komatsu T, Nakagawa A, Tsuchida E, Kobayashi S (2003) Compatibility in vitro of albumin-heme oxygen carrier with blood cell components. J Biomed Mater Res A 66(2):292–297

    Article  Google Scholar 

  • Huraux C, Ankri A, Eyraud D et al (2001) Hemostatic changes in patients receiving hydroxyethyl starch: The influence of ABO blood group. Anesth Analg 92:1396–1401

    Article  Google Scholar 

  • Iwasaki K, Iwashita Y, Ikeda K, Uematsu T (1986) Efficacy and saftey of hemoglobin-polyethlene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid. Artif Organs 10(6):470–474

    Article  Google Scholar 

  • Jahr JS, Lurie F, Gosselin R, Lin JS, Wong L, Owings JT, Larkin E (2002) Effects of hemoglobin glutamer-250 (bovine) (HBOC-201, Hemopure) on coagulation testing. Am J Ther 9:431–436

    Article  Google Scholar 

  • Jahr JS, Weeks DL, Desai P, Lim JC, Butch AW, Gunther RA, Driessen B (2008a) Does OxyVita, a new-generation hemoglobin-based oxygen carrier, or oxyglobin, acutely interfere with coagulation compared with normal saline or 6% hetastarch? An ex vivo thrombelastography study. J Cardiothorac Vasc Anesth 22:34–39

    Article  Google Scholar 

  • Jahr JS, Mackenzie C, Pearce B, Pitman A, Greenburg AG (2008b) HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma-Injury Infect Crit Care 64(6):1484–1497

    Article  Google Scholar 

  • Jahr JS, Liu H, Albert O, Gull A, Moallempour M, Lim J, Gosselin R (2010) Does HBOC-201 (Hemopure) affect platelet function in orthopedic surgery: a single-site analysis from a multicenter study? Am J Ther 17:140–147

    Article  Google Scholar 

  • Jahr JS, Sadighi A, Doherty L, Li A, Kim HW (2011) In chemistry and biochemistry of oxygen therapeutics: from transfusion to artificial blood. Mozzarelli A, Bettati S (eds) (2011) John Wiley and Sons, Ltd., pp 301–316

    Google Scholar 

  • Jahr JS, Sadighi Akha A, Holtby R (2012) Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products. publ Curr Drug Discov Technol 9:158–65

    Google Scholar 

  • James MF (2004) Hele′t E, Potgieter, Ellis P. The effect of hemopure on coagulation in clinically relevant concentrations. Anesth Analg 99(6):1593–1597

    Article  Google Scholar 

  • Jamnicki M, Bombeli T, Seifert B, Zollinger A, Camenzind V, Pasch T, Spahn DR (2000) Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation. Anesthesiology 93(5):1231–1237

    Article  Google Scholar 

  • Johnson VV, Swiatkowski SA (2007) Scientific aspects of supplying blood to distant military theaters. Transfus Med 14:694–699

    Google Scholar 

  • Kim HW, Greenburg AG (2006) Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others. Artif blood Substit Immobil Biotechnol 34:537–550

    Article  Google Scholar 

  • Kim HW, Stubdal H, Greenburg AG (1992) Coagulation dynamics after hemodilution with polyhemoglobin. Surg Gynecol Obstet 175(219–26):22

    Google Scholar 

  • Lee DH, Bardossy L, Peterson N, Blajchman MA (2000) O-raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits. Blood 96(10):3630–3636

    Google Scholar 

  • Lefkowitz JB (2008) Coagulation pathway and physiology. In: Kottke-Marchant K (ed) An Algorithmic Approach to hemostasis testing. College of American Pathologists, Northfield, pp 3–12

    Google Scholar 

  • Leytin V, Mazer D, Mody M, Garvey B, Freedman J (2003) Hemolink, an o-raffinose cross link haemoglobin-based oxygen carrier, does not affect activation and function of human platelets in whole blood. Br J Haematol 120(3):535–541

    Article  Google Scholar 

  • Mammen EF (1998) PFA-100 system: a new method for assesment of platelet dysfunction. Semin Thromb Haemost 24:195–202

    Article  Google Scholar 

  • Moallempour M, Jahr JS, Lim JC, Weeks D, Butch A, Driessen B (2009) Methemoglobin effects on coagulation: a dose-response study with HBOC-200 (Oxyglobin) in a thrombelastogram model. J Cardiothorac Vasc Anesth 23(1):41–47

    Article  Google Scholar 

  • Ning J, Chang TM (1990) In vivo effects of stroma-free hemoglobin and polyhemoglobin on coagulation factors in rats. Int J Artif Organs 13(8):509–516

    Google Scholar 

  • Reid TE (2003) Hb-based oxygen carriers: are we there yet? Transfusion 43:280–287

    Article  Google Scholar 

  • Sakai H, Hara H, Yuasa M, Tsai AG, Takeoka S, Tsuchida E, Intaglietta M (2002) Am J Phys-Heart Circ Phys 279:H908– H915

    Google Scholar 

  • Savitsky JP, Doczi J, Black J, Arnold JD (1978) A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 23(1):73–80

    Google Scholar 

  • Saxena R, Wijnhoud AD, Carton H, Hacke W, Kaste M, Przybelski RJ, Stern KN, Koudstaa PJ (1999) Stroke 30:993–996

    Google Scholar 

  • Squires JE (2002) Artificial Blood. Science 295:1002–1005

    Article  Google Scholar 

  • Standl T, Burmeister MA, Horn EP, Wilhelm S, Knoefel WT (1998) Schulte am Esch J. Bovine haemoglobin-based oxygen carrier for patients undergoing haemodilution before liver resection. Br J Anaesth 80(2):189–194

    Article  Google Scholar 

  • Strauss RG, Pennell BJ, Stump DC (2002) A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 42:27–36

    Article  Google Scholar 

  • TEG (2005) 5000 User’s manual. Niles, IL, Haemoscope Inc, P 178

    Google Scholar 

  • Uszynski L, Schier J, Rudowski W, Daszynski J (1976) Effects of stroma-free haemoglobin solution on the blood-clotting system in dogs. Eur Surg Res 8(3):201–210

    Google Scholar 

  • Weeks DL, Jahr JS, Lim JC, Butch AW, Driessen D (2008) Does Hextend® impair coagulation compared to 6% hetastarch: an ex vivo TEG study. Am J Ther 15:225–230

    Article  Google Scholar 

  • Williams JP, Tseuda K, Vandermeersch E, Bourke DL, Jahr JS (2002) Transfusion requirements in Phase III study of HBOC-201 (Hemopure®, Hemoglobin gutamer-250, bovine), a bovine hemoglobin based blood substitute. Transfusion 42:S49–030I

    Google Scholar 

  • Winslow RM (2000) Blood Substitutes. Adv Drug Deliv Rev 40:131–142

    Article  Google Scholar 

  • Winslow RM (2003) Current status of blood substitute research: towards a new paradigm. J Intern Med 253:508–517

    Article  Google Scholar 

  • Wong NS, Chan TM (2007) Polyhemoglobin-fibrinogen: a novel oxygen carrier with platelet-like properties in a hemodiluted setting. Artif Cell Blood Substit Immobil Biotecnol 35(5):481–489

    Article  Google Scholar 

  • Zhang N, Jia Y, Chen G, Cabrales P, Palmer AF (2011) Tissue Eng Part A 17:927–940

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, David Geffen School of Medicine at UCLA, Ronald Reagan UCLA Medical Center, 757 Westwood Plaza, Suite 3325, Los Angeles, CA, 90095, USA

    Jonathan S. Jahr, Molly Chung & Afsaneh Anvarhosseini

  2. Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI, 02912, USA

    Hae Won Kim

Authors
  1. Jonathan S. Jahr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Molly Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Afsaneh Anvarhosseini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hae Won Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan S. Jahr .

Editor information

Editors and Affiliations

  1. Brown University, Barrington, Rhode Island, USA

    Hae Won Kim

  2. Brown University, Barrington, Rhode Island, USA

    A. Gerson Greenburg

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jahr, J.S., Chung, M., Anvarhosseini, A., Kim, H.W. (2013). Effects of Hemoglobin-Based Oxygen Carriers on Blood Coagulation. In: Kim, H., Greenburg, A. (eds) Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40717-8_34

Download citation

Publish with us

Policies and ethics

Search

Navigation